世界のIgEアレルギー血液検査市場:医療機器パイプライン分析2016

◆英語タイトル:IgE Allergy Blood Tests - Medical Devices Pipeline Assessment, 2016
◆商品コード:GDME0151EPD
◆発行会社(調査会社):GlobalData
◆発行日:2016年3月11日
◆ページ数:41
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥277,500見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥555,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD7,500 ⇒換算¥832,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、IgEアレルギー血液検査のグローバル製品パイプライン動向について調査・分析し、以下の構成でお届けいたします。
・IgEアレルギー血液検査の概要
・IgEアレルギー血液検査の開発動向:開発段階別分析
・IgEアレルギー血液検査の開発動向:セグメント別分析
・IgEアレルギー血液検査の開発動向:領域別分析
・IgEアレルギー血液検査の開発動向:規制Path別分析
・IgEアレルギー血液検査の開発動向:承認日(推定)別分析
・企業別IgEアレルギー血液検査の開発動向(パイプライン製品、進行中の治験)
・IgEアレルギー血液検査の最近動向
【レポートの概要】

IgE Allergy Blood Tests – Medical Devices Pipeline Assessment, 2016

Summary

GlobalData’s Medical Devices sector report, “IgE Allergy Blood Tests – Medical Devices Pipeline Assessment, 2016″ provides an overview of IgE Allergy Blood Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key IgE Allergy Blood Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the IgE Allergy Blood Tests under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of IgE Allergy Blood Tests and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of IgE Allergy Blood Tests under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

【レポートの目次】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 6
2.1 IgE Allergy Blood Tests Overview 6
3 Products under Development 7
3.1 IgE Allergy Blood Tests – Pipeline Products by Stage of Development 7
3.2 IgE Allergy Blood Tests – Pipeline Products by Territory 8
3.3 IgE Allergy Blood Tests – Pipeline Products by Regulatory Path 9
3.4 IgE Allergy Blood Tests – Pipeline Products by Estimated Approval Date 10
4 IgE Allergy Blood Tests – Pipeline Products under Development by Companies 11
4.1 IgE Allergy Blood Tests Companies – Pipeline Products by Stage of Development 11
4.2 IgE Allergy Blood Tests – Pipeline Products by Stage of Development 12
5 IgE Allergy Blood Tests Companies and Product Overview 13
5.1 Abionic SA Company Overview 13
5.1.1 Abionic SA Pipeline Products & Ongoing Clinical Trials Overview 13
5.2 Amerimmune Company Overview 15
5.2.1 Amerimmune Pipeline Products & Ongoing Clinical Trials Overview 15
5.3 Atomo Diagnostics Pty Limited Company Overview 17
5.3.1 Atomo Diagnostics Pty Limited Pipeline Products & Ongoing Clinical Trials Overview 17
5.4 AXO Science S.A.S. Company Overview 18
5.4.1 AXO Science S.A.S. Pipeline Products & Ongoing Clinical Trials Overview 18
5.5 Biovator AB Company Overview 20
5.5.1 Biovator AB Pipeline Products & Ongoing Clinical Trials Overview 20
5.6 Children’s Hospital Boston Company Overview 21
5.6.1 Children’s Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview 21
5.7 China Medical Technologies, Inc. Company Overview 23
5.7.1 China Medical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 23
5.8 Cytognos, S.L. Company Overview 25
5.8.1 Cytognos, S.L. Pipeline Products & Ongoing Clinical Trials Overview 25
5.9 HOB Biotech Group Co., Ltd. Company Overview 26
5.9.1 HOB Biotech Group Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 26
5.10 Hycor Biomedical Inc. Company Overview 27
5.10.1 Hycor Biomedical Inc. Pipeline Products & Ongoing Clinical Trials Overview 27
5.11 Institut fur Produktqualitat GmbH Company Overview 30
5.11.1 Institut fur Produktqualitat GmbH Pipeline Products & Ongoing Clinical Trials Overview 30
5.12 The Binding Site Group Ltd. Company Overview 31
5.12.1 The Binding Site Group Ltd. Pipeline Products & Ongoing Clinical Trials Overview 31
5.13 The University of Queensland Company Overview 32
5.13.1 The University of Queensland Pipeline Products & Ongoing Clinical Trials Overview 32
5.14 University of Connecticut Health Center Company Overview 33
5.14.1 University of Connecticut Health Center Pipeline Products & Ongoing Clinical Trials Overview 33
5.15 University of Nottingham Company Overview 34
5.15.1 University of Nottingham Pipeline Products & Ongoing Clinical Trials Overview 34
5.16 VEGA Ltd Company Overview 36
5.16.1 VEGA Ltd Pipeline Products & Ongoing Clinical Trials Overview 36
6 IgE Allergy Blood Tests- Recent Developments 37
7 Appendix 38
7.1 Methodology 38
7.2 About GlobalData 40
7.3 Contact Us 41
7.4 Disclaimer 41

1.1 List of Tables
Table 1: IgE Allergy Blood Tests - Pipeline Products by Stage of Development 7
Table 2: IgE Allergy Blood Tests - Pipeline Products by Territory 8
Table 3: IgE Allergy Blood Tests - Pipeline Products by Regulatory Path 9
Table 4: IgE Allergy Blood Tests - Pipeline Products by Estimated Approval Date 10
Table 5: IgE Allergy Blood Tests Companies - Pipeline Products by Stage of Development 11
Table 6: IgE Allergy Blood Tests - Pipeline Products by Stage of Development 12
Table 7: Abionic SA Pipeline Products & Ongoing Clinical Trials Overview 13
Table 8: abioKIT - Product Status 14
Table 9: abioKIT - Product Description 14
Table 10: Amerimmune Pipeline Products & Ongoing Clinical Trials Overview 15
Table 11: Basophile Panel - Product Status 15
Table 12: Basophile Panel - Product Description 15
Table 13: CD69 and IgE Receptor Expression Assay - Product Status 16
Table 14: CD69 and IgE Receptor Expression Assay - Product Description 16
Table 15: Atomo Diagnostics Pty Limited Pipeline Products & Ongoing Clinical Trials Overview 17
Table 16: AtomoRapid - Allergy - Product Status 17
Table 17: AtomoRapid - Allergy - Product Description 17
Table 18: AXO Science S.A.S. Pipeline Products & Ongoing Clinical Trials Overview 18
Table 19: Companion Diagnostic Test - Allergy - Product Status 18
Table 20: Companion Diagnostic Test - Allergy - Product Description 18
Table 21: Diagnostic Test - Allergy - Product Status 19
Table 22: Diagnostic Test - Allergy - Product Description 19
Table 23: Biovator AB Pipeline Products & Ongoing Clinical Trials Overview 20
Table 24: Cytokine Profile Assay - Product Status 20
Table 25: Cytokine Profile Assay - Product Description 20
Table 26: Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview 21
Table 27: Biomarker Assay - Allergy - Product Status 22
Table 28: Biomarker Assay - Allergy - Product Description 22
Table 29: China Medical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 23
Table 30: Diagnostic Assay - Total IgE - Product Status 24
Table 31: Diagnostic Assay - Total IgE - Product Description 24
Table 32: Cytognos, S.L. Pipeline Products & Ongoing Clinical Trials Overview 25
Table 33: Diagnosis Flow Cytometry Kit - Type 1 Hypersensitivity - Product Status 25
Table 34: Diagnosis Flow Cytometry Kit - Type 1 Hypersensitivity - Product Description 25
Table 35: HOB Biotech Group Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 26
Table 36: HOB Biotech Diagnostic Assay - Allergy - Product Status 26
Table 37: HOB Biotech Diagnostic Assay - Allergy - Product Description 26
Table 38: Hycor Biomedical Inc. Pipeline Products & Ongoing Clinical Trials Overview 27
Table 39: HYTEC 288 PLUS - Eosinophil Cationic Protein Test - Product Status 28
Table 40: HYTEC 288 PLUS - Eosinophil Cationic Protein Test - Product Description 28
Table 41: HYTEC 288 PLUS - Tryptase Test - Product Status 29
Table 42: HYTEC 288 PLUS - Tryptase Test - Product Description 29
Table 43: Institut fur Produktqualitat GmbH Pipeline Products & Ongoing Clinical Trials Overview 30
Table 44: Diagnostic Test - Allergy - Product Status 30
Table 45: Diagnostic Test - Allergy - Product Description 30
Table 46: The Binding Site Group Ltd. Pipeline Products & Ongoing Clinical Trials Overview 31
Table 47: SPAplus - Immunoglobulin E Assay - Product Status 31
Table 48: SPAplus - Immunoglobulin E Assay - Product Description 31
Table 49: The University of Queensland Pipeline Products & Ongoing Clinical Trials Overview 32
Table 50: Diagnostic Assay - Allergy - Product Status 32
Table 51: Diagnostic Assay - Allergy - Product Description 32
Table 52: University of Connecticut Health Center Pipeline Products & Ongoing Clinical Trials Overview 33
Table 53: Ultrasensitive Peanut Allergy Test - Product Status 33
Table 54: Ultrasensitive Peanut Allergy Test - Product Description 33
Table 55: University of Nottingham Pipeline Products & Ongoing Clinical Trials Overview 34
Table 56: Allergy Test - Product Status 35
Table 57: Allergy Test - Product Description 35
Table 58: VEGA Ltd Pipeline Products & Ongoing Clinical Trials Overview 36
Table 59: Microarray Based Allergen Diagnostic Kit - Product Status 36
Table 60: Microarray Based Allergen Diagnostic Kit - Product Description 36
Table 61: Glossary 39

1.2 List of Figures
Figure 1: IgE Allergy Blood Tests - Pipeline Products by Stage of Development 7
Figure 2: IgE Allergy Blood Tests - Pipeline Products by Territory 8
Figure 3: IgE Allergy Blood Tests - Pipeline Products by Regulatory Path 9
Figure 4: IgE Allergy Blood Tests - Pipeline Products by Estimated Approval Date 10

【掲載企業】

Abionic SA
Amerimmune
Atomo Diagnostics Pty Limited
AXO Science S.A.S.
Biovator AB
Children's Hospital Boston
China Medical Technologies, Inc.
Cytognos, S.L.
HOB Biotech Group Co., Ltd.
Hycor Biomedical Inc.
Institut fur Produktqualitat GmbH
The Binding Site Group Ltd.
The University of Queensland
University of Connecticut Health Center
University of Nottingham
VEGA Ltd

【レポートのキーワード】

IgEアレルギー血液検査

★調査レポート[世界のIgEアレルギー血液検査市場:医療機器パイプライン分析2016]販売に関する免責事項
★調査レポート[世界のIgEアレルギー血液検査市場:医療機器パイプライン分析2016]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆